Resistance to human cytomegalovirus infection may be influenced by genetic polymorphisms of the tumour necrosis factor-alpha and interleukin-1 receptor antagonist genes

Scandinavian Journal of Infectious Diseases

Volumn 30, Issue 5, 1998, Pages 447-449

  Hurme, Mikko ^a   Helminen, Merja ^b  

^a UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALLELE; ARTICLE; BLOOD DONOR; CYTOMEGALOVIRUS INFECTION; GENETIC POLYMORPHISM; HUMAN; HUMAN CYTOMEGALOVIRUS; HUMAN EXPERIMENT; INFLAMMATION; NORMAL HUMAN; VIRUS RESISTANCE;

ADULT; ALLELES; CYTOMEGALOVIRUS INFECTIONS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HETEROZYGOTE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; POLYMORPHISM, GENETIC; RECEPTORS, INTERLEUKIN-1; RECEPTORS, TUMOR NECROSIS FACTOR; SIALOGLYCOPROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032411170     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365549850161403     Document Type: Article

References (18)

1. Griffiths PD, Grundy JE. Molecular biology and immunology of cytomegalovirus. Biochem J 1987; 241: 313-24.
2. Taylor-Wiedeman J, Sissons JGB, Borysiewicz LK, Sinclair JH. Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J Gen Virol 1991; 72: 2059-64.
3. Rinaldo CR, Carney WP, Richter BS, Black PH, Hirsch MS. Mechanism of immunosuppression in cytomegaloviral mononucleosis. J Infect Dis 1980; 141: 488-95.
4. Iwamoto GK, Monick MM, Clark BD, Auron PE, Stinski MF, Hunninghake GW. Modulation of interleukin 1 beta gene expression by the immediate early genes of human cytomegalovirus. J Clin Invest 1990; 85: 1853-7.
5. Nokta MA, Hassan MI, Loesch K, Pollard RB. Human cytomegalovirus-induced immunosuppression. Relationship to tumor necrosis factor-dependent release of arachidonic acid and prostaglandin E2 in human monocytes. J Clin Invest 1996; 97: 2635-41.
6. Iwamoto GK, Konicek SA. Cytomegalovirus immediate early genes upregulate interleukin-6 gene expression. J Invest Med 1997; 45: 175-82.
7. See DM, Khemka P, Sahl L, Bui T, Tilles JG. The role of natural killer cells in viral infections. Scand J Immunol 1997; 46: 217-24.
8. Wilson AG, di Giovine FS, Duff GW. Genetics of tumour necrosis factor-α in autoimmune, infectious, and neoplastic diseases. J Inflamm 1995; 45: 1-12.
9. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94: 3195-9.
10. McGuire W, Hill AVS, Allsopp CEM, Greenwood BM, Kwiatkowski D. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 1994; 371: 508-11.
11. Tarlow JK, Blakemore AIF, Lennard A, Solari R, Hughes HN, Steinkasser A, Duff GW. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 1993; 91: 403-4.
12. Hurme M, Lahdenpohja N, Santtila S. IL-1 and IL-10 gene polymorphisms in infectious and autoimmune diseases. Ann Med, in press.
13. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res 1988; 16: 1215-5.
14. Wilson AG, di Giovine FS, Blakemore AIF, Duff GW. Single base polymorphism in the human tumor necrosis factor alpha (TNFα) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1992; 1: 353-3.
15. Larsson S, Söderberg-Naucle'r C, Wang F-Z, Möller E. Cytomegalovirus DNA can be detected in peripheral blood mononuclear cells from all seropositive and most seronegative healthy blood donors over time. Transfusion 1998; 38: 271-8.
16. Mandrup-Poulsen T, Pociot F, Molvig J, Shapiro L, Nilsson P, Emdal T, Roder M, Kjems LL, Dinarello CA, Nerup J. Monokine antagonism is reduced in patients with IDDM. Diabetes 1994; 43: 1242-7.
17. Hurme M, Santtila S. IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1β genes. Eur J Immunol 1998; 28: 2598-602.
18. Santtila S, Savinainen K, Hurme M. Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1β production in vitro. Scand J Immunol 1998; 47: 195-8.